Post by LabConnect

We’re pleased to announce that Richard Harris has been appointed CEO of LabConnect. Rich brings 30+ years of leadership experience, with a proven track record of launching innovative technology products leveraging AI, driving growth, executing strategic acquisitions, and building high-performing teams. This marks his fourth CEO role, and in his previous positions at TrustEngine, SparkPost, and AddThis, he led each company to high growth and profitability; SparkPost and AddThis ultimately achieving successful acquisitions. Rich succeeds Wes Wheeler, who is retiring after leading LabConnect through a period of significant growth and transformation. We are grateful for his leadership and the strong foundation he helped build. As clinical trials become increasingly complex and global, LabConnect’s differentiated approach combining scientific expertise, global laboratory partnerships, integrated logistics, and innovative technology, positions us to continue delivering for our clients and partners. We look forward to building on this strong momentum under Rich’s leadership. Read more: https://lnkd.in/gw6DKFjZ #ClinicalResearch #ClinicalTrials #CentralLabs #SampleManagement #LabLikeNoOther